+44 (0) 20 7549 9987 | USA callers: +1 212 220 8419

Contact Us Now

“Biomaterials Market Report is set to have rapid growth due growing industrialization in both developed and developing nations, strong government support, suitable strategic framework, and continuous R&D at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report

04 September 2019
Pharma

Visiongain has launched a new pharma report Biomaterials Market Report 2019-2029 : By Product (Natural, Metallic, Ceramics, Polymers), By Application (Cardiovascular, Orthopedics, Plastic Surgery), Regional and Segment Forecasts

The global Biomaterials market is poised for rapid growth between 2019 and 2029. Factors such as increased funds and subsidies from government agencies around the world for the development of new biomaterials, the growing demand for medical implants and the growing incidence of cardiovascular disease are driving the growth of the biomaterials market.

Technological innovations in the field of biomaterials are leading to the development of advanced products, which in turn is working in favor of the market. The expansion of the geriatric population base worldwide and the consequent increase in the prevalence of cardiovascular and orthopedic disorders are providing a problem to the market.

Biomaterials are now widely used in health care sectors such as cardiovascular, orthopedic, dental, plastic, wound repair, ophthalmology and neurological conditions. Furthermore, they are used in various advanced health technologies such as cosmetic surgery, tissue engineering, medical implants and advanced drug delivery.

Leading companies featured in the report include DSM; BASF SE; Evonik Industries AG.; Berkeley Advanced Biomaterials, Inc.; CAM Bioceramics BV; Carpenter Technology Corporation; Invibio Ltd.; Zimmer Biomet Holdings, Inc.; Covalon Technologies Ltd.; Collagen Matrix, Inc.; Medtronic, Inc.; Purac Biomaterials; Ticona GmbH; Osteotech, Inc.; and Bayer AG.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

18 April 2024

Read

Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

17 April 2024

Read

Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034

The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.

12 April 2024

Read

Visiongain Publishes Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034

The global Inflammatory Bowel Diseases (IBD) Drugs market was valued at US$27.53 billion in 2023 and is projected to grow at a CAGR of 6.2% during the forecast period 2024-2034.

11 April 2024

Read